Published online August 1, 2006
PEDIATRICS Vol. 118 No. 2 August 2006, pp. 698-703 (doi:10.1542/peds.2006-0178)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, R. N.
Right arrow Articles by Roth, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, R. N.
Right arrow Articles by Roth, D. R.
Related Collections
Right arrow Genitourinary Tract
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Treatment of Vesicoureteral Reflux Using Endoscopic Injection of Nonanimal Stabilized Hyaluronic Acid/Dextranomer Gel: Initial Experience in Pediatric Patients by a Single Surgeon

Richard N. Yu, MD, PhDa and David R. Roth, MDa,b

a Scott Department of Urology, Baylor College of Medicine, Houston, Texas
b Department of Pediatric Urology, Texas Children’s Hospital, Houston, Texas

OBJECTIVE. Endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel is an increasingly recognized treatment option for vesicoureteral reflux. The procedure is minor compared with open surgery and, when successful, avoids the need for long-term antibiotic prophylaxis. We present data from our first 18 months using nonanimal stabilized hyaluronic acid/dextranomer gel to treat children with vesicoureteral reflux.

PATIENTS AND METHODS. Pediatric patients aged ≤15 years with uncomplicated primary vesicoureteral reflux were recruited for endoscopic treatment with nonanimal stabilized hyaluronic acid/dextranomer gel. A follow-up voiding cystourethrogram was scheduled at ≥2 weeks after treatment, and vesicoureteral reflux resolution was defined as grade 0. Repeat nonanimal stabilized hyaluronic acid/dextranomer gel treatment was offered to patients with persistent vesicoureteral reflux.

RESULTS. Of 120 patients treated, 6 were lost to follow-up, and 7 were yet to undergo posttreatment voiding cystourethrogram. The 107 remaining patients (efficacy population) had a mean age of 4.1 years (range: 0.5–15.0), and the median reflux grade was 2 (range: 1–5). The mean time to follow-up voiding cystourethrogram was 9.7 weeks (range: 2–26). Vesicoureteral reflux was resolved in 82.2% of patients and 86.9% of ureters after initial endoscopic treatment with nonanimal stabilized hyaluronic acid/dextranomer gel. The overall reflux resolution rate for patients increased to 90.7% after a second treatment in 14 patients. Two patients reported postoperative flank pain, although this was mild and transient in nature. No other adverse events were reported. No patients underwent open surgery for vesicoureteral reflux.

CONCLUSIONS. Endoscopic treatment with nonanimal stabilized hyaluronic acid/dextranomer gel is effective in a high proportion of children with vesicoureteral reflux and, in our opinion, may be considered as a first-line treatment option.


Key Words: NASHA/Dx gel • vesicoureteral reflux • endoscopic injection • pediatric • ureter

Abbreviations: VUR—vesicoureteral reflux • UTI—urinary tract infection • FDA—U.S. Food and Drug Administration • NASHA/Dx—nonanimal stabilized hyaluronic acid/dextranomer • VCUG—voiding cystourethrogram • STING—subureteric transurethral injection • HIT—hydrodistention-implantation technique


Accepted Mar 3, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in UrologyHome page
G. Lackgren and A. Stenberg
Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment
Therapeutic Advances in Urology, August 1, 2009; 1(3): 131 - 141.
[Abstract] [PDF]